Sigilon Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2022.
  • Sigilon Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$1.64M, a 3521% decline year-over-year.
  • Sigilon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.61M, a 203% decline from 2021.
  • Sigilon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.55M, a 99.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.61M -$3.16M -203% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $1.55M -$188M -99.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $189M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.